CVI Investments Inc. 13D and 13G filings for Atossa Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-07 4:09 pm Sale |
2024-12-31 | 13G | Atossa Therapeutics, Inc. ATOS |
CVI Investments Inc. | 5,662,500 4.300% |
-2,100,000 (-27.05%) |
Filing |
| 2022-02-14 3:16 pm Purchase |
2021-12-31 | 13G | Atossa Therapeutics, Inc. ATOS |
CVI Investments Inc. | 7,762,500 5.800% |
3,962,500 (+104.28%) |
Filing |
| 2021-01-15 11:42 am Purchase |
2021-01-06 | 13G | Atossa Therapeutics, Inc. ATOS |
CVI Investments Inc. | 3,800,000 5.300% |
1,495,711 (+64.91%) |
Filing |
| 2021-01-15 11:41 am Purchase |
2020-12-31 | 13G | Atossa Therapeutics, Inc. ATOS |
CVI Investments Inc. | 2,304,289 4.900% |
179,289 (+8.44%) |
Filing |
| 2020-12-18 12:01 pm Purchase |
2020-12-09 | 13G | Atossa Therapeutics, Inc. ATOS |
CVI Investments Inc. | 2,125,000 8.500% |
2,125,000 (New Position) |
Filing |